Patent details
EP2359856
Title:
Formulation of human antibodies for treating TNF-alpha associated disorders
Basic Information
- Publication number:
- EP2359856
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101826105
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Formulation of human antibodies for treating TNF-alpha associated disorders
- French Title of Invention:
- Formulation d'anticorps humains pour le traitement de troubles associés au TNF-alpha
- German Title of Invention:
- Formulierung humaner Antikörper zur Behandlung von TNF-alpha-assoziierten Erkrankungen
- SPC Number:
-
Dates
- Filing date:
- 15/08/2003
- Grant date:
- 10/05/2017
- EP Publication Date:
- 24/08/2011
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/05/2017
- EP B1 Publication Date:
- 10/05/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/08/2018
- Expiration date:
- 15/08/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/05/2017
-
-
- Name:
- AbbVie Biotechnology Ltd.
- Address:
- Clarendon House
2, Church Street, HM 11 Hamilton, Bermuda (BM)
Agent
- Name:
- Office FREYLINGER S.A.
- From:
- 12/07/2017
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Krause, Hans-Juergen
- Address:
- Germany (DE)
2
- Name:
- Dickes, Michael
- Address:
- Germany (DE)
3
- Name:
- Baust, Lisa
- Address:
- Germany (DE)
Priority
- Priority Number:
- 222140
- Priority Date:
- 16/08/2002
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 9/19;
A61K 39/395;
A61K 47/26;
Publication
European Patent Bulletin
- Issue number:
- 201719
- Publication date:
- 10/05/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 03/08/2017
- Last Annual Fee Paid Number:
- 15
- Last Annual Fee Paid Amount:
- 213 Euro
- Payer:
- MDC (HENKEL PATENT)